Obama: U.S. forces to move to Afghan support role in spring

Jan 11 (Reuters) - Tiger Woods may guarantee packed galleries but even the oil-rich Qataris cannot afford the former world number one's appearance fee for the only European Tour event in the Gulf state. The American's involvement at the Jan. 23-26 Qatar Masters would cost a whopping $3 million, said Qatar Golf Association president Hassan al Nuaimi. "Tiger Woods demands $3 million just for an appearance, if he were to compete - which is not worth paying for a tournament of $2.5 million prize money," he told the Doha News. ...

Read More..

Sprint confirms it will launch BlackBerry 10 later this year

Title Post: Sprint confirms it will launch BlackBerry 10 later this year
Url Post: http://www.news.fluser.com/sprint-confirms-it-will-launch-blackberry-10-later-this-year/
Link To Post : Sprint confirms it will launch BlackBerry 10 later this year
Rating:
100%

based on 99998 ratings.
5 user reviews.
Author: Fluser SeoLink
Thanks for visiting the blog, If any criticism and suggestions please leave a comment

Read More..

Ben Affleck Wins Critics Choice Best Director, Thanks the Academy That Snubbed Him

By Paul Chi and Melody Chiu

01/11/2013 at 12:50 PM EST

Take that, Academy!

Hours after Ben Affleck was snubbed by the Academy of Motion Picture Arts and Sciences, which did not give him a Best Director nomination for his film Argo, he won in the same category at Thursday night's 18th Annual Critics Choice Movie Awards in Santa Monica.

"I'd like to thank the Academy," joked Affleck, 40, while on stage to collect his hardware. "I'm kidding, I'm kidding! This is the one that counts."

Affleck's victory was greeted by thunderous applause and a standing ovation from the crowd. His absence from the field of Best Director Oscar nominees was considered one of the biggest shocks when the nominations were announced Thursday morning. Meanwhile, Argo was nominated for a Best Picture Oscar.

"It actually is very, very cool for me," Affleck said while accepting his Critics Choice Award. "There was a time where the Ben Affleck Critics Award was a Saturday Night Live sketch, so this is a very, very cool and exciting thing."

Affleck, who attended the show without wife Jennifer Garner, went on to thank his family by saying, "My daughter wrote my name on my hand for luck. I don't know how that works, but I guess it worked," he said. "I want to thank my kids and I want to thank my wife, without whom I would not be anywhere, much less here."

When Affleck returned to his table, George Clooney – a producer on Argo – greeted him with a congratulatory hug and smile, while fellow nominee David O. Russell (Silver Linings Playbook) offered his congrats by rubbing Affleck's back.

Argo also was named best picture at the Critics Choice Awards.

Read More..

Flu more widespread in US; eases off in some areas

NEW YORK (AP) — Flu is more widespread across the nation, but the number of hard-hit states has declined, health officials said Friday.

Flu season started early this winter, and includes a strain that tends to make people sicker. Health officials have forecast a potentially bad flu season, following last year's unusually mild one.

The latest numbers, however, hint that the flu season may already have peaked in some spots.

Flu was widespread in 47 states last week, up from 41 the week before, the Centers for Disease Control and Prevention said on Friday. Many cases may be mild. The only states without widespread flu are California, Mississippi and Hawaii

The hardest hit states dropped to 24 from 29. Those are states where large numbers of people have been treated for flu-like illness.

Those with less activity include Florida, Arkansas and South Carolina in South, the first region hit in the current flu season.

Nationally, 20 children have died from the flu. There is no running tally of adult deaths, but the CDC estimates that the flu kills about 24,000 people in an average year.

Flu vaccinations are recommended for everyone 6 months or older. Health officials are still recommending vaccinations, even in areas with widespread flu reports.

Nearly 130 million doses of flu vaccine were distributed this year, and at least 112 million have been used, according to CDC officials.

Vaccine is still available, but supplies may have run low in some locations, health officials say.

Also on Friday, CDC officials said a recent study of more than 1,100 people has concluded the current flu vaccine is 62 percent effective. That's in line with how effective the vaccine has been in other years.

The flu vaccine is reformulated each year, and officials say this year's version is a good match to the viruses going around.

Flu usually peaks in midwinter. Symptoms can include fever, cough, runny nose, head and body aches and fatigue. Some people also suffer vomiting and diarrhea, and some develop pneumonia or other severe complications.

Most people with flu have a mild illness. But people with severe symptoms should see a doctor. They may be given antiviral drugs or other medications to ease symptoms.

___

Online:

CDC flu: http://www.cdc.gov/flu/index.htm

Read More..

Wall Street falls, pressured by Wells Fargo, banks

NEW YORK (Reuters) - Stocks edged lower on Friday after Wells Fargo & Co , the first major bank to kick off fourth-quarter earnings season for the financial sector, reported a decline in net interest margin despite a record profit in the latest quarter.

Wells Fargo, the fourth-biggest U.S. bank and the nation's largest home lender, said its fourth-quarter net interest margin - a key measure of how much money banks make from loans - fell, even as profit jumped 24 percent. The bank also made fewer mortgage loans than in the third quarter.

"It (Wells Fargo results) is weighing on the sector. We are keeping our fingers crossed that this won't be a sector thing and more confined to Wells Fargo, but it's definitely playing a factor today," said Larry Peruzzi, senior equity trader at Cabrera Capital Markets LLC in Boston.

The bank's shares fell 1.4 percent to $34.92. The S&P 500 financial sector index <.gspf> fell 0.6 percent and the KBW Banks index <.bkx> fell 1 percent. Bank of America Corp , JPMorgan Chase & Co and Citigroup Inc are due to report results next week.

Overall earnings were expected to grow by 1.9 percent in this earnings season, according to Thomson Reuters data.

The Dow Jones industrial average <.dji> was up 6.12 points, or 0.05 percent, at 13,477.34. The Standard & Poor's 500 Index <.spx> was down 2.37 points, or 0.16 percent, at 1,469.75. The Nasdaq Composite Index <.ixic> was down 2.19 points, or 0.07 percent, at 3,119.56.

Also keenly watched Friday were shares of Dow component Boeing , which fell 2.6 percent to $75.11 after a cracked cockpit window and an oil leak on separate flights in Japan compounded safety concerns about its new 787 Dreamliner. The U.S. Department of Transportation said the jet would be subject to a review of its critical systems by regulators.

Best Buy shares rallied after its results showed a bit of a turnaround in its U.S. stores, though same-store sales were flat during the key holiday season. Shares jumped 12 percent to $13.69.

Basic materials shares were pressured after China's annual consumer inflation rate picked up to a seven-month high, narrowing the scope for the central bank to boost the economy by easing monetary policy. The S&P basic materials sector <.gspm> fell 0.6 percent.

Dendreon Corp shares jumped 14.7 percent to $5.85 after Sanford C. Bernstein upgraded the drugmaker's stock to "outperform" from "market-perform" and said it could be one of the best performers in 2013.

(Editing by Bernadette Baum, Nick Zieminski)

Read More..

Twin explosions kill 56 in Pakistani city of Quetta: police

(Reuters) - Twin explosions killed at least 56 people in the Pakistani city of Quetta on Thursday evening, a police official said, hours after a bombing in Quetta's market killed 11.

The death toll in the latest blasts could rise, according to Deputy Inspector of Police Hamid Shakil.

The first explosion, in a snooker hall, appeared to be a suicide bombing, local residents said. About ten minutes later, a car bomb went off, they said, and five policemen and a cameraman were among the dead from that blast.

(Reporting by Katharine Houreld; Editing by Mark Heinrich)

Read More..

Is BlackBerry back? Strong early BlackBerry 10 demand could signal RIM comeback

After hitting a rough patch that seemed to last for most of 2012, Research In Motion (RIMM) may finally see the light at the end of the tunnel. RIM plans to unveil the finished version of its next-generation BlackBerry 10 platform at a press conference on January 30th, and at least one new smartphone is expected to be revealed during the event. Generating interest in BlackBerry 10 within the crowded global smartphone market will be no easy task for the struggling vendor, but if demand at top Canadian Rogers is any indication, RIM is off to a promising start.

[More from BGR: ‘Apple is done’ and Surface tablet is cool, according to teens]

In mid-December, Rogers began taking reservations for RIM’s first BlackBerry 10-powered handset. The carrier offered almost no information about the BlackBerry smartphone, which has not yet been announced, but asked subscribers interested in purchasing the device to register on the company’s website.

[More from BGR: iPhone 5 now available with unlimited service, no contract on Walmart’s $ 45 Straight Talk plan]

BGR approached Rogers on Thursday to see how subscriber response has been thus far.

“While we can’t release the total number of reservations we have received for the BlackBerry 10 all-touch device, we can say that customer interest is definitely strong and reservations continue daily,” a RIM spokesperson told BGR via email.

The strong response from Rogers subscribers despite being provided only with the knowledge that the device will feature an all-touch form factor and will run the BlackBerry 10 OS is a good sign for RIM.

The vendor has a number of difficult challenges ahead, and convincing current BlackBerry users to upgrade en masse is near the top of the list. Strong early demand at Rogers for RIM’s first BlackBerry 10 handset is clearly a positive sign in this regard, as most early reservations likely came from current BlackBerry subscribers.

This article was originally published on BGR.com

Wireless News Headlines – Yahoo! News

Read More..

Monopoly Pits Cats Lovers Against Dog Lovers in New Contest

People Pets

By Maggie Coughlan

01/10/2013 at 01:45 PM EST

Are you a dog person or a cat person? The answer to that question isn't just for your online dating profile!

Monopoly is pitting dog and cat lovers against each other in a new contest to eliminate one of its iconic tokens and replace it with a new one.

Via Facebook, Hasbro, the toy and game company behind the nearly 78-year-old board game, is asking fans to part with one of the die-cast tokens used to represent players – the Scottie dog, top hat, wheelbarrow, clothes iron, battleship, race car, thimble or shoe.

Classic Monopoly pieces

Courtesy Hasbro

One token will "go to jail," but fans are invited to vote a brand new piece into its place. Choices are a cat, diamond ring, guitar, toy robot and helicopter.

While the clothes iron, racer, thimble, shoe, top hat and battleship were part of the original game when it was released in 1935, the Scottie and wheelbarrow didn't join the lineup until the early 1950s. Once the votes are tallied, the new version of the board game will be available in "mid to late" 2013, the company predicts.

"The tokens are one of the most iconic parts of the Monopoly game, and we know that people are emotionally tied to their favorite one," Eric Nyman, Senior Vice President and Global Brand Leader for Hasbro Gaming, said in a statement.

Read More..

Retooling Pap test to spot more kinds of cancer

WASHINGTON (AP) — For years, doctors have lamented that there's no Pap test for deadly ovarian cancer. Wednesday, scientists reported encouraging signs that one day, there might be.

Researchers are trying to retool the Pap, a test for cervical cancer that millions of women get, so that it could spot early signs of other gynecologic cancers, too.

How? It turns out that cells can flake off of tumors in the ovaries or the lining of the uterus, and float down to rest in the cervix, where Pap tests are performed. These cells are too rare to recognize under the microscope. But researchers from Johns Hopkins University used some sophisticated DNA testing on the Pap samples to uncover the evidence — gene mutations that show cancer is present.

In a pilot study, they analyzed Pap smears from 46 women who already were diagnosed with either ovarian or endometrial cancer. The new technique found all the endometrial cancers and 41 percent of the ovarian tumors, the team reported Wednesday in the journal Science Translational Medicine.

This is very early-stage research, and women shouldn't expect any change in their routine Paps. It will take years of additional testing to prove if the so-called PapGene technique really could work as a screening tool, used to spot cancer in women who thought they were healthy.

"Now the hard work begins," said Hopkins oncologist Dr. Luis Diaz, whose team is collecting hundreds of additional Pap samples for more study and is exploring ways to enhance the detection of ovarian cancer.

But if it ultimately pans out, "the neat part about this is, the patient won't feel anything different," and the Pap wouldn't be performed differently, Diaz added. The extra work would come in a lab.

The gene-based technique marks a new approach toward cancer screening, and specialists are watching closely.

"This is very encouraging, and it shows great potential," said American Cancer Society genetics expert Michael Melner.

"We are a long way from being able to see any impact on our patients," cautioned Dr. Shannon Westin of the University of Texas MD Anderson Cancer Center. She reviewed the research in an accompanying editorial, and said the ovarian cancer detection would need improvement if the test is to work.

But she noted that ovarian cancer has poor survival rates because it's rarely caught early. "If this screening test could identify ovarian cancer at an early stage, there would be a profound impact on patient outcomes and mortality," Westin said.

More than 22,000 U.S. women are diagnosed with ovarian cancer each year, and more than 15,000 die. Symptoms such as pain and bloating seldom are obvious until the cancer is more advanced, and numerous attempts at screening tests have failed.

Endometrial cancer affects about 47,000 women a year, and kills about 8,000. There is no screening test for it either, but most women are diagnosed early because of postmenopausal bleeding.

The Hopkins research piggybacks on one of the most successful cancer screening tools, the Pap, and a newer technology used along with it. With a standard Pap, a little brush scrapes off cells from the cervix, which are stored in a vial to examine for signs of cervical cancer. Today, many women's Paps undergo an additional DNA-based test to see if they harbor the HPV virus, which can spur cervical cancer.

So the Hopkins team, funded largely by cancer advocacy groups, decided to look for DNA evidence of other gynecologic tumors. It developed a method to rapidly screen the Pap samples for those mutations using standard genetics equipment that Diaz said wouldn't add much to the cost of a Pap-plus-HPV test. He said the technique could detect both early-stage and more advanced tumors. Importantly, tests of Paps from 14 healthy women turned up no false alarms.

The endometrial cancers may have been easier to find because cells from those tumors don't have as far to travel as ovarian cancer cells, Diaz said. Researchers will study whether inserting the Pap brush deeper, testing during different times of the menstrual cycle, or other factors might improve detection of ovarian cancer.

Read More..

Wall Street climbs on China data; S&P nears resistance

NEW YORK (Reuters) - Stocks climbed on Thursday on optimism about global growth spurred by stronger-than-expected exports in China, the world's second-biggest economy, though gains in the S&P 500 were capped at a resistance level near a 5-year high.

Financial and energy stocks were the day's top gainers in afternoon trading. The financial sector index <.gspf> rose 0.8 percent and the energy sector <.gspe> was up 0.6 percent.

The benchmark Standard & Poor's 500 index hovered near a five-year closing peak of 1,466.47. On Friday, the index had closed at its highest since December 2007.

"The market is technically right at the level of resistance, near 1,465-1,467," said Randy Frederick, managing director of active trading and derivatives at Charles Schwab.

"A solid breakthrough above the level would be the start of a next leg higher, but it looks like it is going to be difficult to break above that level for now," Frederick said, citing concerns about the corporate earnings season and impending negotiations over the U.S. debt ceiling.

By late morning, the S&P 500 had erased almost all its gains from earlier Thursday in minutes. Some traders said the dip was triggered by a trade in the options market that prompted a large amount of S&P futures to hit the market at the same time, sending the S&P 500 index down rapidly.

Data showed China's export growth rebounded sharply to a seven-month high in December, a strong finish to the year after seven straight quarters of slowdown.

The Dow Jones industrial average <.dji> was up 36.20 points, or 0.27 percent, at 13,426.71. The Standard & Poor's 500 Index <.spx> was up 5.11 points, or 0.35 percent, at 1,466.13. The Nasdaq Composite Index <.ixic> was up 0.05 points, or 0.00 percent, at 3,105.86.

In company news, shares of upscale jeweler Tiffany dropped 4.3 percent to $60.53 after it said earnings for the year through January 31 will be at the lower end of its forecast.

U.S.-traded Nokia shares jumped 18 percent to $4.42 after the Finnish handset maker said its fourth-quarter results were better than expected and that the mobile phone business achieved underlying profitability.

Herbalife Ltd stepped up its defense against activist investor Bill Ackman, stressing it was a legitimate company with a mission to improve nutrition and help public health. The stock was down 2.4 percent at $39.15.

U.S. data showed claims for unemployment benefits rose last week, though seasonal volatility made it difficult to get a clear picture of the labor market's health.

Also, U.S. wholesale inventories rose more than expected in November and sales rose by the most in more than 1-1/2 years. The market's reaction to both reports was muted.

(Editing by Bernadette Baum)

Read More..